Type 1 diabetes reversed in lab experiment. 26 March 2021 An experimental treatment could reverse type 1 diabetes for millions of people, helping them regenerate their own insulin-producing capacity and restore their normal blood glucose balance. Type 1 diabetes is an autoimmune condition in which the immune system is actively destroying the cells in the pancreas which produce insulin. The University of Utah Health scientists found that giving mice a single dose of a human antibody that suppress the actions of glucagon, a hormone involved in glucose regulation, led to an incredible transformation in the pancreas. It suppressed the symptoms of diabetes and increased insulin cell mass by seven times. “These animals go from requiring insulin injections to never requiring a diabetes treatment again. They maintain normal blood glucose long after we stop the treatment,” says William L Holland the study’s corresponding author. “What this implies for millions of people who have type 1 diabetes is that there is a chance we could eventually regenerate their own insulin-producing capacity, restore their normal blood glucose balance, and hopefully help make progress toward being free of the disease.” But researchers say they are still a long way from finding a cure. “This research is certainly promising, but it is likely just the first step of many before we can determine if this approach will work in humans with type 1 diabetics,” Holland says. The study has been published in the Proceedings of the National Academy of Sciences (PNAS). You can read more here.
Media releases 14 August 2026 Beyond blood glucose: New national partnership to measure how Australians with diabetes are really doing For the first time, the Australian Unity Wellbeing Index will be used to build the most complete picture yet of how diabetes affects Australian’s lives beyond clinical outcomes and health system costs, thanks to a partnership between Diabetes Australia, Deakin University, and the Australian Unity Support Foundation. Continue Reading
Media releases 13 August 2026 PMOS in spotlight for diabetes prevention A new partnership between Diabetes Australia and the Medibank Better Health Research Hub will support Monash University to develop a primary care model to better detect and prevent type 2 diabetes in women living with polyendocrine metabolic ovarian syndrome (PMOS). Continue Reading
News 7 August 2026 Brett Fenton appointed Adjunct Clinical Fellow at UTS Diabetes Australia warmly welcomes Chief Health Officer Brett Fenton's appointment as an Adjunct Clinical Fellow at the University of Technology Sydney (UTS). Continue Reading